NCT00091273View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

June 30, 2007

Conditions
Ovarian CancerPrimary Peritoneal Cavity Cancer
Interventions
BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

ovarian cancer peptide vaccine

BIOLOGICAL

sargramostim

BIOLOGICAL

tetanus toxoid helper peptide

PROCEDURE

adjuvant therapy

Trial Locations (1)

22908

University of Virginia Cancer Center, Charlottesville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Virginia

OTHER

NCT00091273 - Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter